Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study

Saurabh Zalpuri, Jaap Jan Zwaginga, J G van der Bom, Saurabh Zalpuri, Jaap Jan Zwaginga, J G van der Bom

Abstract

Introduction: Individuals exposed to red blood cell alloantigens through transfusion, pregnancy or transplantation may produce antibodies against the alloantigens. Alloantibodies can pose serious clinical problems such as delayed haemolytic reactions and logistic problems, for example, to obtain timely and properly matched transfusion blood for patients in which new alloantibodies are detected.

Objective: The authors hypothesise that the particular clinical conditions (eg, used medication, concomitant infection, cellular immunity) during which transfusions are given may contribute to the risk of immunisation. The aim of this research was to examine the association between clinical, environmental and genetic characteristics of the recipient of erythrocyte transfusions and the risk against erythrocyte alloimmunisation during that transfusion episode. METHODS AND ANALYSIS STUDY DESIGN: Incident case-cohort study.

Setting: Secondary care, nationwide study (within the Netherlands) including seven hospitals, from January 2005 to December 2011.

Study population: Consecutive red cell transfused patients at the study centres.

Inclusion: The study cohort comprises of consecutive red blood cell transfused patients at the study centre. EXCLUSION: Patients with transfusions before the study period and/or pre-existing alloantibodies.Cases defined as first time alloantibody formers; Controls defined as transfused individuals matched (on number of transfusions) to cases and have not formed an alloantibody.

Statistical analysis: Logistic regression models will be used to assess the association between the risk to develop antibodies and potential risk factors, adjusted for other risk factors.

Ethics and dissemination: Approval at each local ethics regulatory committee will be obtained. Data will be coded for privacy reasons. Patients will be sent a letter and an information brochure explaining the purpose of the study. A consent form in presence of the study coordinator will be signed before the blood taking commences. Investigators will submit progress summary of the study to study sponsor regularly. Investigators will notify the accredited ethics board of the end of the study within a period of 8 weeks.

Conflict of interest statement

Competing interests: None.

Figures

Figure 1
Figure 1
Flowchart of study design for the matched control group.
Figure 2
Figure 2
Implicating period of clinical data collection.

References

    1. Norol F, Nadjahi J, Bachir D, et al. [Transfusion and alloimmunization in sickle cell anemia patients]. Transfus Clin Biol 1994;1:27–34
    1. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999;39:763–71
    1. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990;30:532–5
    1. Zalpuri S, Zwaginga J, Cessie S, et al. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2012;102:144–9
    1. Asfour M, Narvios A, Lichtiger B. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. MedGenMed 2004;6:22.
    1. Ramsey G, Hahn LF, Cornell FW, et al. Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989;47:993–5
    1. Shukla JS, Chaudhary RK. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis. Indian J Pathol Microbiol 1999;42:299–302
    1. Reisner EG, Kostyu DD, Phillips G, et al. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens 1987;30:161–6
    1. Bacon N, Patten E, Vincent J. Primary immune response to blood group antigens in burned children. Immunohematology 1991;7:8–11
    1. Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007;47:2066–71
    1. Hoeltge GA, Domen RE, Rybicki LA, et al. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42–5
    1. Seyfried H, Walewska I. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Mater Med Pol 1990;22:21–5
    1. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006;46:1526–36
    1. Reviron D, Dettori I, Ferrera V, et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion 2005;45:956–9
    1. Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006;132:374–8
    1. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006;46:1328–33
    1. Mason PM, Parham P. HLA class I region sequences, 1998. Tissue Antigens 1998;51:417–66
    1. Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004;364:2113–21
    1. Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008;26:1731–6
    1. Dhiman N, Ovsyannikova IG, Cunningham JM, et al. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007;195:21–9
    1. Larcombe L, Rempel JD, Dembinski I, et al. Differential cytokine genotype frequencies among Canadian Aboriginal and Caucasian populations. Genes Immun 2005;6:140–4
    1. McDade TW, Rutherford JN, Adair L, et al. Population differences in associations between C-reactive protein concentration and adiposity: comparison of young adults in the Philippines and the United States. Am J Clin Nutr 2009;89:1237–45

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다